國家衛生研究院 NHRI:
English  |  正體中文  |  简体中文  |  全文筆數/總筆數 : 12145/12927 (94%)
造訪人次 : 857710      線上人數 : 762
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜尋範圍 查詢小技巧:
  • 您可在西文檢索詞彙前後加上"雙引號",以獲取較精準的檢索結果
  • 若欲以作者姓名搜尋,建議至進階搜尋限定作者欄位,可獲得較完整資料
  • 進階搜尋
    主頁登入上傳說明關於NHRI管理 到手機版

    子類別

    專利 [0/12]
    期刊論文 [49/50]
    圖書 [1/1]
    會議論文/會議摘要 [1/1]

    鄰近社群


    余佳益 [17/17]
    余冠儀 [40/40]
    冷治湘 [61/89]
    劉士任 [121/149]
    劉家齊 [45/52]
    司徒惠康 [71/72]
    吳綺容 [84/84]
    周彥宏 [46/58]
    宋旺洲 [33/34]
    廖經倫 [32/32]
    張仲明 [2/2]
    張堯 [44/44]
    曾凡真 [34/34]
    曾才騰 [9/9]
    李敏西 [60/64]
    杜鴻運 [50/50]
    楊采菱 [133/134]
    潘建雄 [18/19]
    羅秀容 [96/97]
    胡勇誌 [23/23]
    莊再成 [104/153]
    蕭樑基 [158/161]
    蘇益仁(2002-2015) [190/195]
    許修誌(2005-2010) [1/1]
    許素菁 [27/30]
    謝鐸源(2006-2014) [20/27]
    郭書辰 [139/141]
    陳俊宏 [61/62]
    陳信偉 [83/110]
    陳宜君 [38/38]
    陳逢叡 [40/40]
    黃盈綺 [6/6]
    齊嘉鈺 [46/46]
    McDonald LC(1998-2000) [12/12]
    何曼德(1997-2002) [38/39]
    其他 [177/177]
    朱清良(2005-2007) [4/4]
    梁蘭蘭(1998-2006) [6/6]
    黃崑巖(1999-2004) [4/4]

    社群統計


    近3年內發表的文件:9(14.06%)
    含全文筆數:51(79.69%)

    文件下載次數統計
    下載大於0次:51(100.00%)
    下載大於100次:48(94.12%)
    檔案下載總次數:23204(0.43%)

    最後更新時間: 2024-11-28 17:36

    上傳排行

    資料載入中.....

    下載排行

    資料載入中.....

    RSS Feed RSS Feed
    跳至:
    或輸入年份:
    由新到舊排序 由最舊的開始

    顯示項目1-50 / 64. (共2頁)
    1 2 > >>
    每頁顯示[10|25|50]項目

    日期題名關聯
    2024-09-10 Boosting DNA vaccine power by lipid nanoparticles surface engineered with amphiphilic bioresorbable copolymer Molecular Therapy Nucleic Acids. 2024 Sep 10;35(3):Article number 102261.
    2024-06-19 pH-responsive beta-glucans-complexed mRNA in LNPs as an oral vaccine for enhancing cancer immunotherapy Advanced Materials. 2024 Jun 19;Article in Press.
    2024-03-14 Lipid nanoparticle-encapsulated DNA vaccine robustly induce superior immune responses to the mRNA vaccine in Syrian hamsters Molecular Therapy Methods and Clinical Development. 2024 Mar 14;32(1):Article number 101169.
    2023-12 The stability and immunogenicity of formalin-inactivated Enterovirus A71 whole virion vaccine after ten years of low temperature storage Journal of Microbiology, Immunology and Infection. 2023 Dec;56(6):1121-1128.
    2023-11-06 Enhancing immunity and modulating vaginal microflora against candidal vaginitis through nanoemulsion supplemented with porphyra oligosaccharide as an intravaginal vaccine adjuvant International Journal of Nanomedicine. 2023 Nov 06;18:6333-6346.
    2023-05-29 TLR9 and STING agonists cooperatively boost the immune response to SARS-CoV-2 RBD vaccine through an increased germinal center B cell response and reshaped T helper responses International Journal of Biological Sciences. 2023 May 29;19(9):2897-2913.
    2023-03-24 Propagation and immunological characterization of coxsackievirus A10 in a serum-free HEK293A cell culture system Virus Research. 2023 Mar 24;329:Article number 199101.
    2022-12-02 Omicron-specific mRNA vaccine induced cross-protective immunity against ancestral SARS-CoV-2 infection with low neutralizing antibodies Journal of Medical Virology. 2022 Dec 2;95:Article number e28370.
    2022-11-21 Formulation of SARS-CoV-2 spike protein with CpG oligodeoxynucleotides and squalene nanoparticles modulates immunological aspects following intranasal delivery Pharmaceutics. 2022 Nov 21;14(11):Article number 2539.
    2021-11 Nanoemulsion adjuvant for nasal mucosa and preparation method thereof 2021-11-02(US11160862B2).
    2021-09-27 Hyaluronic acid-glycine-cholesterol conjugate-based nanoemulsion as a potent vaccine adjuvant for T cell-mediated immunity Pharmaceutics. 2021 Sep 27;13(10):Article number 1569.
    2021-09-25 Assessment of adjuvantation strategy of lipid squalene nanoparticles for enhancing the immunogenicity of a SARS-CoV-2 spike subunit protein against COVID-19 International Journal of Pharmaceutics. 2021 Sep 25;607:Article number 121024.
    2021-09 Squalene nanoemulsion reinforces mucosal and immunological fingerprints following intravaginal delivery Biomedicine and Pharmacotherapy. 2021 Sep;141:Article number 111799.
    2021-07-16 Colloidal assemblies composed of polymeric micellar/emulsified systems integrate cancer therapy combining a tumor-associated antigen vaccine and chemotherapeutic regimens Nanomaterials. 2021 Jul 16;11(7):Article number 1844.
    2021-05 Immunogenic peptide containing a b cell epitope of tumor associated antigen L6 2021-05-04(US10995126B2).
    2021-02-21 用於鼻黏膜之奈米級乳液免疫載劑及其製備方法 I719263/2021-02-21
    2021-01-05 Morphology and protein adsorption of aluminum phosphate and aluminum hydroxide and their potential catalytic function in the synthesis of polymeric emulsifiers Colloids and Surfaces. A, Physicochemical and Engineering Aspects. 2021 Jan 5;608:Article number 125564.
    2020-11-30 Type IIb heat labile enterotoxin B subunit as a mucosal adjuvant to enhance protective immunity against H5N1 avian influenza viruses Vaccines. 2020 Nov 30;8(4):Article number 710.
    2020-10-09 Nanoemulsion adjuvantation strategy of tumor-associated antigen therapy rephrases mucosal and immunotherapeutic signatures following intranasal vaccination Journal for ImmunoTherapy of Cancer. 2020 Oct 9;8(2):Article number e001022.
    2020-05-21 Use of PELC/CpG adjuvant for intranasal immunization with recombinant hemagglutinin to develop H7N9 mucosal vaccine Vaccines. 2020 May 21;8(2):Article number 240.
    2020-04-04 Elaboration of charged poly(Lactic-co-Glycolic Acid) microparticles for effective release of tranexamic acid Polymers. 2020 Apr 4;12(4):Article number 808.
    2020-02 One-pot amphiphilic engineering of bioresorbable polymers for constructing colloidal vesicles and prolonging protein delivery Polymer Journal. 2020 Feb;52(2):237-244.
    2019-11-01 包含腫瘤相關抗原L6之B細胞抗原決定位之免疫原胜肽 I675843/2019-11-01
    2019-11 Recombinant hemagglutinin produced from Chinese Hamster Ovary (CHO) stable cell clones and a PELC/CpG combination adjuvant for H7N9 subunit vaccine development Vaccine. 2019 Nov;37(47):6933-6941.
    2019-10 Impact of antigen-adjuvant associations on antigen uptake and antigen-specific humoral immunity in mice following intramuscular injection Biomedicine and Pharmacotherapy. 2019 Oct;118:Article number 109373.
    2019-10 Synthetic peptide of tumour-associated antigen L6 formulated with polymer-based adjuvant enhances anti-tumour effects in mice Annals of Oncology. 2019 Oct;30(Suppl. 5):23.
    2019-01-24 Sorbitan polyester conjugates for stabilizing water-in-oil emulsions and delivering controlled release of bioactive agents AU2016215757/2019-01-24
    2019-01-08 Sorbitan polyester conjugates for stabilizing water-in-oil emulsions and delivering controlled release of bioactive agents US10172945B2/2019-01-08
    2018-11-18 Towards boosting power by encapsulating tranexamic acid into emulsified particles Journal of Chemistry. 2018 Nov 18;2018:Article number 8101540.
    2018-10 Synthesis and thermal investigation of phosphate-functionalized acrylic materials Polymer Journal. 2018 Oct;50(10):967-974.
    2018-04-18 Polysorbasome: A colloidal vesicle contoured by polymeric bioresorbable amphiphiles as an immunogenic depot for vaccine delivery ACS Applied Materials and Interfaces. 2018 Apr 18;10(15):12553-12561.
    2018-02-05 Unsaturated squalene content in emulsion vaccine adjuvants plays a crucial role in ROS-Mediated antigen uptake and cellular immunity Molecular Pharmaceutics. 2018 Feb 5;15(2):420-429.
    2017-11 用於穩定油包水乳液及控制釋放生物活性物質之山梨醇酐聚酯複合體 2017 2017-11-28(CN107405304A).
    2017-09-22 Recombinant hemagglutinin proteins formulated in a novel PELC/CpG adjuvant for H7N9 subunit vaccine development Antiviral Research. 2017 Sep 22;146:213-220.
    2017-09 用於穩定油包水乳液及控制釋放生物活性物質之山梨醇酐聚酯複合體 I598114/2017-09-11
    2017-05 Emulsifying properties and degradation characteristics of bioresorbable polymeric emulsifiers in aqueous solution and oil-in-water emulsion Polymer Degradation and Stability. 2017 May;139:138-142.
    2016-11-09 Degradable emulsion as vaccine adjuvant reshapes antigen-specific immunity and thereby ameliorates vaccine efficacy Scientific Reports. 2016 Nov 09;6:Article number 36732.
    2016-11 Mucosal delivery of a combination adjuvant comprising emulsified fine particles and LD-indolicidin enhances serological immunity to inactivated influenza virus Microbes and Infection. 2016 Nov;18(11):706-709.
    2016-07 Chimeric peptide containing both B and T cells epitope of tumor-associated antigen L6 enhances anti-tumor effects in HLA-A2 transgenic mice Cancer Letters. 2016 Jul;377(2):126-133.
    2016-02-21 新穎抗腸病毒、流感病毒及/或日本腦炎之混合型多價疫苗 I522469/2016-02-21
    2015-11 Design and development of immunomodulatory antigen delivery systems based on peptide/PEG-PLA conjugate for tuning immunity Biomacromolecules. 2015 Nov;16(11):3666-3673.
    2015-10-28 多价疫苗 ZL2011103383577/2015-10-28
    2015-08 Use of recombinant flagellin in oil-in-water emulsions enhances hemagglutinin-specific mucosal IgA production and IL-17 secreting T cells against H5N1 avian influenza virus infection Vaccine. 2015 Aug;33(35):4321-4329.
    2015-04-08 Thermal properties and physicochemical behavior in aqueous solution of pyrene-labeled poly(ethylene glycol)-polylactide conjugate International Journal of Nanomedicine. 2015 Apr 8;10:2815-2822.
    2014-06-11 Immunogenicity studies of bivalent Inactivated virions of EV71/CVA16 formulated with submicron emulsion systems Biomed Research International. 2014 Jun 11;2014:Article number 670506.
    2014-01 A novel emulsion-type adjuvant containing CpG oligodeoxynucleotides enhances CD8+ T-cell-mediated anti-tumor immunity Journal of Controlled Release. 2014 Jan;173(1):158-165.
    2014-01 Disintegration and cancer immunotherapy efficacy of a squalane-in-water delivery system emulsified by bioresorbable poly(ethylene glycol)-block-polylactide Biomaterials. 2014 Jan;35(5):1686-1695.
    2013-11 Formulation and immunological evaluation of a trivalent vaccine comprising emulsified submicron particles and inactivated virions of H5N1/EV71/JEV Human Vaccines and Immunotherapeutics. 2013 Nov ;9(11):2378-2385.
    2013-09 Induction of robust immunity by the emulsification of recombinant lipidated dengue-1 envelope protein domain III Microbes and Infection. 2013 Sep;15(10-11):719-728.
    2013-06-14 Different immunity elicited by recombinant H5N1 hemagglutinin proteins containing pauci-mannose, high-mannose, or complex type N-Glycans PLoS ONE. 2013 Jun 14;8(6):Article number e66719.

    顯示項目1-50 / 64. (共2頁)
    1 2 > >>
    每頁顯示[10|25|50]項目

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回饋